Dudediligence.

Aurinia Pharmaceuticals Inc

AUPHNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$124.4M

7 notices · 4,460,985 sh

Oct 2025 to Oct 2026

Reported ·

$546,373

2 sales · 11 buys · $25.1M bought

Oct 2025 to Sep 2026

The two figures cover different periods.

None of the 2 reported sales carry the 10b5-1 box. Together they are 0.02% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-08-21: Stephen P. Robertson, Form 1442026-06-05: GREGORY KEENAN, Form 1442026-06-04: GREGORY KEENAN, Form 1442026-06-02: GREGORY KEENAN, Form 1442026-05-11: PETER GREENLEAF, Form 1442026-05-11: MATTHEW MAXWELL DONLEY, Form 1442026-05-11: JOSEPH MILLER, Form 1442026-02-27: TANG KEVIN, bought2026-05-29: TANG KEVIN, bought2026-08-21: Robertson Stephen P., sold2026-09-10: Robertson Stephen P., sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-21Stephen P. Robertson, Chief Legal Officer$719,100
47,000 shno plan date144 ↗
Form 4, 2026-08-25: sold 20,975 at $16.97 Form 4 ↗
2026-06-05GREGORY KEENAN, SVP, Chief Medical Officer$158,490
9,593 shno plan dateno Form 4 on file144 ↗
2026-06-04GREGORY KEENAN, SVP, Chief Medical Officer$408,435
25,000 shno plan dateno Form 4 on file144 ↗
2026-06-02GREGORY KEENAN, SVP, Chief Medical Officer$54.1M
25,000 shno plan dateno Form 4 on file144 ↗
2026-05-11PETER GREENLEAF, Chief Executive Officer$49.7M
3,136,201 shno plan dateno Form 4 on file144 ↗
2026-05-11MATTHEW MAXWELL DONLEY, Chief Operating Officer$11.4M
717,688 shno plan dateno Form 4 on file144 ↗
2026-05-11JOSEPH MILLER, Chief Financial Officer$7,927,968
500,503 shno plan dateno Form 4 on file144 ↗